Summary & Overview
CPT 81263: IGH Variable Region Mutation Analysis
CPT code 81263 covers molecular testing for mutations in the VH or variable region of the Immunoglobulin heavy chain locus (IGH@). This genetic analysis is performed by laboratory personnel to detect sequence alterations relevant to B‑cell malignancies and immune‑related disorders. The code represents a specialized molecular pathology service with implications for diagnosis, prognosis, and disease monitoring across clinical hematology and oncology.
Key payers included in national coverage considerations are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for IGH@ variable region testing, common sites of service where the testing is performed, and how the procedure is reported using CPT code 81263. The publication summarizes payer coverage patterns and benchmarks where available, highlights relevant policy updates affecting molecular diagnostic reimbursement, and situates the test within broader laboratory and clinical workflows.
This report is intended to inform laboratory managers, billing professionals, and policy analysts about the role and reporting of CPT code 81263, expected service settings, and the types of operational and policy questions that commonly arise for this molecular diagnostic service.
Billing Code Overview
CPT code 81263 describes a laboratory service that analyzes mutations in the VH (variable heavy) or variable region of the Immunoglobulin heavy chain locus (IGH@). The procedure involves molecular genetic testing performed by a laboratory analyst to identify sequence variations in the immunoglobulin heavy chain, which can inform diagnosis and monitoring of B‑cell neoplasms and related hematologic conditions.
Service Type: Molecular pathology / genetic analysis
Typical Site of Service: Clinical laboratory or hospital laboratory (inpatient or outpatient specimen processing)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of lymphadenopathy and abnormal peripheral blood lymphocyte counts is referred to hematology-oncology after abnormal flow cytometry suggests a clonal B‑cell population. The hematologist orders molecular testing for immunoglobulin heavy chain (IGH) variable region rearrangements to determine clonality and to characterize the VH or variable region of the IGH@ locus. A venous blood sample or fresh/frozen lymph node tissue is collected in the laboratory and transported to a molecular diagnostics lab. The molecular technologist performs 81263 testing using PCR amplification and sequencing or fragment analysis to detect IGH variable-region mutations and clonal rearrangements. Results are reported to the ordering clinician and incorporated into the diagnostic workup for suspected B‑cell lymphoma, chronic lymphocytic leukemia, or assessment of minimal residual disease during or after therapy. Typical site of service is an outpatient clinic or hospital outpatient laboratory; the technical work is performed in a certified molecular diagnostics laboratory with reporting to the provider for clinical interpretation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing for the professional interpretation portion only if technical component billed separately by the lab. |